Inspira Technologies Oxy B.H.N. Ltd. (IINN)
- Previous Close
1.9000 - Open
1.8900 - Bid 1.8400 x 400
- Ask 1.8800 x 400
- Day's Range
1.8360 - 1.9430 - 52 Week Range
0.7610 - 2.4900 - Volume
73,994 - Avg. Volume
1,160,557 - Market Cap (intraday)
32.684M - Beta (5Y Monthly) 2.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9300 - Earnings Date Mar 18, 2024 - Mar 22, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
13.00
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.
inspira-technologies.comRecent News: IINN
Performance Overview: IINN
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IINN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IINN
Valuation Measures
Market Cap
32.68M
Enterprise Value
28.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
5.70
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.55
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-59.53%
Return on Equity (ttm)
-116.54%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.29M
Diluted EPS (ttm)
-0.9300
Balance Sheet and Cash Flow
Total Cash (mrq)
7.36M
Total Debt/Equity (mrq)
15.30%
Levered Free Cash Flow (ttm)
-4.74M